Dr. Shaun Sabico wins the ESMEO-IOF Young Scientist Award Pierre Meunier

Dr. Shaun Sabico received the Pierre Meunier Award for Young Scientists from ESCEO-IOF at a special ceremony held on April 6 at the World Congress on Osteoporosis, Osteoarthritis and Diseases. musculoskeletal disorders (WCO-IOF-ESCEO & # 39; 19 in Paris).

The joint award of the European Society for the Clinical and Economic Aspects of Osteoporosis and Osteoarthritis and Musculoskeletal Disorders (ESCEO) and the International Foundation Against Osteoporosis (IOF) award a young researcher who has demonstrated exceptional scientific merit early in his career, before joining a reputed academic position, and who should be a future leader of opinion in the field of musculoskeletal system.

At the end of the awards ceremony in Paris, Jean-Yves Reginster, President of ESCEO, said:

"Low levels of vitamin D are a major worldwide problem and prevalent in the Middle East, where studies have found high rates of deficiency in the population." Dr. Sabico's commitment and achievements in the advancement of research and education in this important area of ​​musculoskeletal health is exemplary and he is a winner of this year's Young Scientist Pierre Meunier ESCEO-IOF Award. "

Dr. Sabico attended medical training at the University of Santo Tomas, Philippines, and obtained a doctorate in medical science in 2018 at the Warwick Medical School of the University of Warwick, UK, under the tutelage of Professor Philip McTernan and Professor Nbader Al-Daghri. Under the direction of Professor Al-Daghri, Dr. Sabico has contributed to the dissemination of vitamin D sensitization in Saudi Arabia and the Middle East through clinical, epidemiological, genetic and proteomic studies, and has collaborated with experts to develop local and regional guidelines. for vitamin D and osteoporosis. He is currently Deputy Director and new Assistant Professor at the Chair of Chronic Disease Biomarkers at King Saud University in Saudi Arabia. His research focuses on chronic diseases, vitamin D, probiotics and bone markers. He is the author of more than a hundred scientific publications in these fields.

###

World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Disorders (WCO-IOF-ESCEO Paris 2019):

Organized jointly by IOF and ESCEO, the congress is held in Paris, France, from April 4 to 7, 2019. The OMD-IOF-ESCEO is the largest forum annual report to the world for the presentation of clinical research and new advances in the prevention and management of muscle and joint disorders, including sarcopenia and fragility. For more information and to view conference abstracts, visit the website
http: // www.WCO-iof-esceo.org #OsteoCongress

About IOF:

The International Foundation Against Osteoporosis (IOF) is the world's largest non-governmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including scientific research committees and more than 240 patient, physician and researcher societies in 99 sites, work together to make fracture prevention and healthy mobility a priority World Health Care. http: // www.iofbonehealth.org http: // www.Facebook.com / @ iofbonehealth

About ESCEO:

The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) is a non-profit organization that is dedicated to the close interaction between scientists clinics dealing with rheumatic disorders, the pharmaceutical industry developing new compounds in this field, the regulators responsible for the registration of these drugs and health decision makers, to integrate management of osteoporosis and osteoarthritis in the global perspective of the use of health resources. ESCEO aims to provide clinicians with the latest clinical and economic information, allowing them to organize their daily practice from an evidence-based medicine perspective with a conscious perception of costs. http: // www.esceo.org